Latest News about PHAR
Recent news which mentions PHAR
Sotera Health, SMART Global And Other Big Losers From Wednesday
October 06, 2022
From Benzinga
Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday
October 06, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 05, 2022
From Benzinga
Why Sotera Health Shares Are Trading Lower By Around 13%, Here Are 38 Stocks Moving In Wednesday's Mid-Day Session
October 05, 2022
From Benzinga
SMART Global Holdings, Credit Suisse And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
October 05, 2022
From Benzinga
Pharming's Leniolisib Goes Under Priority FDA Review For Rare Immune System Disorder
September 28, 2022
Tickers
PHAR
From Benzinga
From Benzinga
Earnings Scheduled For May 12, 2022
May 12, 2022
From Benzinga
Earnings Scheduled For March 17, 2022
March 17, 2022
From Benzinga
54 Biggest Movers From Yesterday
February 03, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 02, 2022
From Benzinga
33 Stocks Moving In Wednesday's Mid-Day Session
February 02, 2022
From Benzinga
Why Are Pharming Shares Trading Higher Today?
February 02, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 02, 2022
From Benzinga
From InvestorPlace
23 Stocks Moving in Wednesday's Pre-Market Session
February 02, 2022
From Benzinga
24 Stocks Moving in Thursday's Pre-Market Session
November 04, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 28, 2021
From Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
From Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
From Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
From Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
From Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Monday
August 09, 2021
From Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
August 06, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 05, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 20, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.